Helen Tayton-Martin

Helen Tayton-Martin

Company: Adaptimmune

Job title: Chief Business Officer


Industry Leaders’ Fireside Chat: The Opportunity for Next-Gen 8:40 am

Instilling the importance for innovative platforms and technologies to further enhance cell therapy efficacy Reviewing clinical advances of next generation programmes across solid tumours and autoimmunityRead more

day: Conference Day 1 - AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.